Sanchez-Hidalgo JM, Duran-Martinez M, Molero-Payan R, et al. Gastrointestinal stromal tumors: a multidisciplinary challenge. World J Gastroenterol. 2018;24:1925–41.

CAS  PubMed  PubMed Central  Google Scholar 

Arshad J, Ahmed J, Subhawong T, et al. Progress in determining response to treatment in gastrointestinal stromal tumor. Expert Rev Anticancer Ther. 2020;20:279–88.

CAS  PubMed  PubMed Central  Google Scholar 

Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2015;40:39–46.

PubMed  Google Scholar 

Casali PG, Blay JY, Abecassis N, et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;33:20–33.

PubMed  Google Scholar 

Wen Z, He X, Chen C, et al. Evaluation of the efficacy of gastric lymphoma treated with non-surgical therapy using oral and double contrast-enhanced gastric ultrasonography. Med Ultrason. 2023;25:255–62.

PubMed  Google Scholar 

Fanelli GN, Loupakis F, Smyth E, et al. Pathological tumor regression grade classifications in gastrointestinal cancers: role on patient’s prognosis. Int J Surg Pathol. 2019;27:816–35.

PubMed  Google Scholar 

Tong Y, Liu D, Zhang J. Connection and distinction of tumor regression grading systems of gastrointestinal cancer. Pathol Res Pract. 2020;216:153073.

PubMed  Google Scholar 

Expert Committee of Clinical Practice Guideline for the Pathological Diagnosis of Gastrointestinal Stromal Tumor. Clinical practice guideline for the pathological diagnosis of gastrointestinal stromal tumor (2022 version). Zhonghua Bing Li Xue Za Zhi. 2022;51:959–69.

Google Scholar 

Chinese expert consensus and guidelines on oral contrast gastric ultrasonography for scanning technique and imaging acquisition, advanced ultrasound in diagnosis and therapy. 2020;4: 357–65.

Wenying Y, Su Y, Jing S, et al. Comparative study of combined transabdominal and intraluminal ultrasound and enhancement CT on evaluating the treatment effectiveness of molecularly targeted drugs for gastrointestinal stromal tumors. J Chongqing Med Univ. 2020;8:1218–22.

Google Scholar 

Liu Z, Guo J, Li Y, et al. Standardized gastric ultrasound scanning planes with normal anatomical variability. Ultraschall Med. 2019;41:318–22.

PubMed  Google Scholar 

Adler DD, Carson PL, Rubin JM, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol. 1990;16:553–9.

CAS  PubMed  Google Scholar 

Desai J. Response assessment in gastrointestinal stromal tumor. Int J Cancer. 2011;128:1251–8.

CAS  PubMed  Google Scholar 

Ud Din N, Ahmad Z, Arshad H, et al. Gastrointestinal stromal tumors: a clinicopathologic and risk stratification study of 255 cases from Pakistan and review of literature. Asian Pac J Cancer Prev. 2015;16:4873–80.

PubMed  Google Scholar 

Koo DH, Ryu MH, Kim KM, et al. Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor. Cancer Res Treat. 2016;48:1155–66.

PubMed  PubMed Central  Google Scholar 

Lai MY, Kang SY, Sun YT, et al. Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer. BMC Cancer. 2022;22:1031.

CAS  PubMed  PubMed Central  Google Scholar 

Xiao J, Tan Y, Li W, et al. Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: results from a prospective study. Oncol Lett. 2015;9:2680–6.

CAS  PubMed  PubMed Central  Google Scholar 

von Mehren M, Kane JM, Bui MM, et al. NCCN guidelines insights: soft tissue sarcoma, version 1.2021. J Natl Compr Cancer Net. 2020;18:1604–12.

Google Scholar 

Wada N, Takahashi T, Kurokawa Y, et al. Appropriate follow-up strategies for gastrointestinal stromal tumor patients based on the analysis of recurrent interval and patterns [J]. Digestion. 2017;95:115–21.

PubMed  Google Scholar 

Song M, Zhang L, Wang Z, et al. Consistency analysis between pathological and imaging evaluations of gastrointestinal stromal tumor after preoperative targeted therapy [J]. Chin J Clin Oncol. 2024;51:298–301.

Google Scholar 

Shankar S, van Sonnenberg E, Desai J, et al. Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology. 2005;235:892–8.

PubMed  Google Scholar 

Lee JC, Chen CH, Chen TC, et al. Preoperative tyrosine kinase inhibitors risks bowel anastomotic healing in patients with advanced primary and recurrent/metastatic gastrointestinal stromal tumors–-a rose has its thorns. Eur J Surg Oncol. 2019;45:153–9.

PubMed  Google Scholar 

Guo JJ, Tang XB, Qian QF, et al. Application of ultrasonography in predicting the biological risk of gastrointestinal stromal tumors. Scand J Gastroenterol. 2021;57:352–8.

PubMed  Google Scholar 

Zanoni M, Piccinini F, Arienti C, Bevilacqua A, Tesei A. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016;6:19103.

CAS  PubMed  PubMed Central  Google Scholar 

Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. New Engl J Med. 2002;347:472–80.

CAS  PubMed  Google Scholar 

Abu-Amna M, Awadie H, Bar-Sela G. Imatinib-induced gastrointestinal vascular ectasia in a patient with advanced GIST: case report and literature review. Anticancer Res. 2016;36:6151–4.

PubMed  Google Scholar 

Rondonotti E, Marmo R, Petracchini M, et al. The American Society for Gastrointestinal Endoscopy (ASGE) diagnostic algorithm for obscure gastrointestinal bleeding: eight burning questions from everyday clinical practice. Digest Liver Dis. 2012;45:179–85.

Google Scholar 

Romero-Espinosa L, Souza-Gallardo LM, Martínez-Ordaz JL, et al. Obscure gastrointestinal bleeding due to gastrointestinal stromal tumors. Cir Cir. 2016;85:214–9.

PubMed  Google Scholar 

Picchi S, Lassandro G, Mazzotta G, et al. Urgent rare surgical complication assessment of intestinal gastrointestinal stromal tumors. J Endovasc Resusc Trauma Manage. 2024;7:86–92.

Google Scholar 

Ishida T, Takahashi T, Nishida T, et al. New response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor. Gastric Cancer. 2022;25:218–25.

CAS  PubMed  Google Scholar 

Lassau N, Chami L, Koscielny S, et al. Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib [J]. Invest New Drugs. 2012;30:765–71.

CAS  PubMed  Google Scholar